472 related articles for article (PubMed ID: 25833378)
1. Increased efficiency of Campylobacter jejuni N-oligosaccharyltransferase PglB by structure-guided engineering.
Ihssen J; Haas J; Kowarik M; Wiesli L; Wacker M; Schwede T; Thöny-Meyer L
Open Biol; 2015 Apr; 5(4):140227. PubMed ID: 25833378
[TBL] [Abstract][Full Text] [Related]
2. Structural insights from random mutagenesis of Campylobacter jejuni oligosaccharyltransferase PglB.
Ihssen J; Kowarik M; Wiesli L; Reiss R; Wacker M; Thöny-Meyer L
BMC Biotechnol; 2012 Sep; 12():67. PubMed ID: 23006740
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems.
Wacker M; Feldman MF; Callewaert N; Kowarik M; Clarke BR; Pohl NL; Hernandez M; Vines ED; Valvano MA; Whitfield C; Aebi M
Proc Natl Acad Sci U S A; 2006 May; 103(18):7088-93. PubMed ID: 16641107
[TBL] [Abstract][Full Text] [Related]
4. Desulfovibrio desulfuricans PglB homolog possesses oligosaccharyltransferase activity with relaxed glycan specificity and distinct protein acceptor sequence requirements.
Ielmini MV; Feldman MF
Glycobiology; 2011 Jun; 21(6):734-42. PubMed ID: 21098514
[TBL] [Abstract][Full Text] [Related]
5. A conserved DGGK motif is essential for the function of the PglB oligosaccharyltransferase from Campylobacter jejuni.
Barre Y; Nothaft H; Thomas C; Liu X; Li J; Ng KKS; Szymanski CM
Glycobiology; 2017 Oct; 27(10):978-989. PubMed ID: 28922740
[TBL] [Abstract][Full Text] [Related]
6. Engineered oligosaccharyltransferases with greatly relaxed acceptor-site specificity.
Ollis AA; Zhang S; Fisher AC; DeLisa MP
Nat Chem Biol; 2014 Oct; 10(10):816-22. PubMed ID: 25129029
[TBL] [Abstract][Full Text] [Related]
7. Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.
Wetter M; Kowarik M; Steffen M; Carranza P; Corradin G; Wacker M
Glycoconj J; 2013 Jul; 30(5):511-22. PubMed ID: 23053636
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and topology of bacterial oligosaccharyltransferase PglB.
Li L; Woodward R; Ding Y; Liu XW; Yi W; Bhatt VS; Chen M; Zhang LW; Wang PG
Biochem Biophys Res Commun; 2010 Apr; 394(4):1069-74. PubMed ID: 20331969
[TBL] [Abstract][Full Text] [Related]
9. Unexpected reactivity and mechanism of carboxamide activation in bacterial N-linked protein glycosylation.
Lizak C; Gerber S; Michaud G; Schubert M; Fan YY; Bucher M; Darbre T; Aebi M; Reymond JL; Locher KP
Nat Commun; 2013; 4():2627. PubMed ID: 24149797
[TBL] [Abstract][Full Text] [Related]
10. Investigation into the efficiency of diverse N-linking oligosaccharyltransferases for glycoengineering using a standardised cell-free assay.
Lehri B; Atkins E; Scott TA; Abouelhadid S; Wren BW; Cuccui J
Microb Biotechnol; 2024 Jun; 17(6):e14480. PubMed ID: 38858807
[TBL] [Abstract][Full Text] [Related]
11. Oligosaccharyltransferase PglB of Campylobacter jejuni is a glycoprotein.
Bokhari H; Maryam A; Shahid R; Siddiqi AR
World J Microbiol Biotechnol; 2019 Dec; 36(1):9. PubMed ID: 31858269
[TBL] [Abstract][Full Text] [Related]
12. Substitute sweeteners: diverse bacterial oligosaccharyltransferases with unique N-glycosylation site preferences.
Ollis AA; Chai Y; Natarajan A; Perregaux E; Jaroentomeechai T; Guarino C; Smith J; Zhang S; DeLisa MP
Sci Rep; 2015 Oct; 5():15237. PubMed ID: 26482295
[TBL] [Abstract][Full Text] [Related]
13. N-Glycosylation with synthetic undecaprenyl pyrophosphate-linked oligosaccharide to oligopeptides by PglB oligosaccharyltransferase from Campylobacter jejuni.
Ishiwata A; Taguchi Y; Lee YJ; Watanabe T; Kohda D; Ito Y
Chembiochem; 2015 Mar; 16(5):731-7. PubMed ID: 25688550
[TBL] [Abstract][Full Text] [Related]
14. Relaxed acceptor site specificity of bacterial oligosaccharyltransferase in vivo.
Schwarz F; Lizak C; Fan YY; Fleurkens S; Kowarik M; Aebi M
Glycobiology; 2011 Jan; 21(1):45-54. PubMed ID: 20847188
[TBL] [Abstract][Full Text] [Related]
15. In vivo production of a novel glycoconjugate vaccine against Shigella flexneri 2a in recombinant Escherichia coli: identification of stimulating factors for in vivo glycosylation.
Kämpf MM; Braun M; Sirena D; Ihssen J; Thöny-Meyer L; Ren Q
Microb Cell Fact; 2015 Jan; 14():12. PubMed ID: 25612741
[TBL] [Abstract][Full Text] [Related]
16. Characterization of N-linked protein glycosylation in Helicobacter pullorum.
Jervis AJ; Langdon R; Hitchen P; Lawson AJ; Wood A; Fothergill JL; Morris HR; Dell A; Wren B; Linton D
J Bacteriol; 2010 Oct; 192(19):5228-36. PubMed ID: 20581208
[TBL] [Abstract][Full Text] [Related]
17. A catalytically essential motif in external loop 5 of the bacterial oligosaccharyltransferase PglB.
Lizak C; Gerber S; Zinne D; Michaud G; Schubert M; Chen F; Bucher M; Darbre T; Zenobi R; Reymond JL; Locher KP
J Biol Chem; 2014 Jan; 289(2):735-46. PubMed ID: 24275651
[TBL] [Abstract][Full Text] [Related]
18. Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins.
Cuccui J; Wren B
J Pharm Pharmacol; 2015 Mar; 67(3):338-50. PubMed ID: 25244672
[TBL] [Abstract][Full Text] [Related]
19. Rationally designed short polyisoprenol-linked PglB substrates for engineered polypeptide and protein N-glycosylation.
Liu F; Vijayakrishnan B; Faridmoayer A; Taylor TA; Parsons TB; Bernardes GJ; Kowarik M; Davis BG
J Am Chem Soc; 2014 Jan; 136(2):566-9. PubMed ID: 24377322
[TBL] [Abstract][Full Text] [Related]
20. Campylobacter jejuni free oligosaccharides: function and fate.
Nothaft H; Liu X; Li J; Szymanski CM
Virulence; 2010; 1(6):546-50. PubMed ID: 21178500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]